Cargando…

Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion

The gut microbiota metabolizes drugs and alters their efficacy and toxicity. Diet alters drugs, the metabolism of the microbiota, and the host. However, whether diet-triggered metabolic changes in the microbiota can alter drug responses in the host has been largely unexplored. Here we show that diet...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Wenfan, Saba, James A., Yao, Cong-Hui, Hilzendeger, Michael A., Drangowska-Way, Anna, Joshi, Chintan, Mony, Vinod K., Benjamin, Shawna B., Zhang, Sisi, Locasale, Jason, Patti, Gary J., Lewis, Nathan, O’Rourke, Eyleen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244588/
https://www.ncbi.nlm.nih.gov/pubmed/32444616
http://dx.doi.org/10.1038/s41467-020-16220-w
_version_ 1783537606208782336
author Ke, Wenfan
Saba, James A.
Yao, Cong-Hui
Hilzendeger, Michael A.
Drangowska-Way, Anna
Joshi, Chintan
Mony, Vinod K.
Benjamin, Shawna B.
Zhang, Sisi
Locasale, Jason
Patti, Gary J.
Lewis, Nathan
O’Rourke, Eyleen J.
author_facet Ke, Wenfan
Saba, James A.
Yao, Cong-Hui
Hilzendeger, Michael A.
Drangowska-Way, Anna
Joshi, Chintan
Mony, Vinod K.
Benjamin, Shawna B.
Zhang, Sisi
Locasale, Jason
Patti, Gary J.
Lewis, Nathan
O’Rourke, Eyleen J.
author_sort Ke, Wenfan
collection PubMed
description The gut microbiota metabolizes drugs and alters their efficacy and toxicity. Diet alters drugs, the metabolism of the microbiota, and the host. However, whether diet-triggered metabolic changes in the microbiota can alter drug responses in the host has been largely unexplored. Here we show that dietary thymidine and serine enhance 5-fluoro 2′deoxyuridine (FUdR) toxicity in C. elegans through different microbial mechanisms. Thymidine promotes microbial conversion of the prodrug FUdR into toxic 5-fluorouridine-5′-monophosphate (FUMP), leading to enhanced host death associated with mitochondrial RNA and DNA depletion, and lethal activation of autophagy. By contrast, serine does not alter FUdR metabolism. Instead, serine alters E. coli’s 1C-metabolism, reduces the provision of nucleotides to the host, and exacerbates DNA toxicity and host death without mitochondrial RNA or DNA depletion; moreover, autophagy promotes survival in this condition. This work implies that diet-microbe interactions can alter the host response to drugs without altering the drug or the host.
format Online
Article
Text
id pubmed-7244588
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72445882020-06-03 Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion Ke, Wenfan Saba, James A. Yao, Cong-Hui Hilzendeger, Michael A. Drangowska-Way, Anna Joshi, Chintan Mony, Vinod K. Benjamin, Shawna B. Zhang, Sisi Locasale, Jason Patti, Gary J. Lewis, Nathan O’Rourke, Eyleen J. Nat Commun Article The gut microbiota metabolizes drugs and alters their efficacy and toxicity. Diet alters drugs, the metabolism of the microbiota, and the host. However, whether diet-triggered metabolic changes in the microbiota can alter drug responses in the host has been largely unexplored. Here we show that dietary thymidine and serine enhance 5-fluoro 2′deoxyuridine (FUdR) toxicity in C. elegans through different microbial mechanisms. Thymidine promotes microbial conversion of the prodrug FUdR into toxic 5-fluorouridine-5′-monophosphate (FUMP), leading to enhanced host death associated with mitochondrial RNA and DNA depletion, and lethal activation of autophagy. By contrast, serine does not alter FUdR metabolism. Instead, serine alters E. coli’s 1C-metabolism, reduces the provision of nucleotides to the host, and exacerbates DNA toxicity and host death without mitochondrial RNA or DNA depletion; moreover, autophagy promotes survival in this condition. This work implies that diet-microbe interactions can alter the host response to drugs without altering the drug or the host. Nature Publishing Group UK 2020-05-22 /pmc/articles/PMC7244588/ /pubmed/32444616 http://dx.doi.org/10.1038/s41467-020-16220-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ke, Wenfan
Saba, James A.
Yao, Cong-Hui
Hilzendeger, Michael A.
Drangowska-Way, Anna
Joshi, Chintan
Mony, Vinod K.
Benjamin, Shawna B.
Zhang, Sisi
Locasale, Jason
Patti, Gary J.
Lewis, Nathan
O’Rourke, Eyleen J.
Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion
title Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion
title_full Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion
title_fullStr Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion
title_full_unstemmed Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion
title_short Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion
title_sort dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244588/
https://www.ncbi.nlm.nih.gov/pubmed/32444616
http://dx.doi.org/10.1038/s41467-020-16220-w
work_keys_str_mv AT kewenfan dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT sabajamesa dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT yaoconghui dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT hilzendegermichaela dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT drangowskawayanna dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT joshichintan dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT monyvinodk dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT benjaminshawnab dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT zhangsisi dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT locasalejason dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT pattigaryj dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT lewisnathan dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion
AT orourkeeyleenj dietaryserinemicrobiotainteractionenhanceschemotherapeutictoxicitywithoutalteringdrugconversion